HealthCor Management as of Sept. 30, 2020
Portfolio Holdings for HealthCor Management
HealthCor Management holds 38 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zimmer Holdings (ZBH) | 7.1 | $178M | 1.3M | 136.14 | |
| UnitedHealth (UNH) | 6.4 | $159M | 511k | 311.77 | |
| Medtronic SHS (MDT) | 5.8 | $146M | 1.4M | 103.92 | |
| Horizon Therapeutics Pub L SHS | 5.6 | $139M | 1.8M | 77.68 | |
| Madrigal Pharmaceuticals (MDGL) | 5.4 | $134M | 1.1M | 118.73 | |
| Iqvia Holdings (IQV) | 5.3 | $133M | 841k | 157.63 | |
| Aurinia Pharmaceuticals (AUPH) | 5.2 | $131M | 8.9M | 14.73 | |
| Abbvie (ABBV) | 4.6 | $116M | 1.3M | 87.59 | |
| Hca Holdings (HCA) | 4.6 | $116M | 926k | 124.68 | |
| Regeneron Pharmaceuticals (REGN) | 4.3 | $107M | 190k | 559.78 | |
| Nevro (NVRO) | 4.1 | $102M | 731k | 139.30 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.9 | $99M | 362k | 272.12 | |
| Humana (HUM) | 3.8 | $95M | 229k | 413.89 | |
| Guardant Health (GH) | 3.6 | $89M | 798k | 111.78 | |
| Neurocrine Biosciences (NBIX) | 3.6 | $89M | 927k | 96.16 | |
| Cooper Cos Com New | 3.3 | $81M | 242k | 337.12 | |
| Arcturus Therapeutics Hldg I Call Option (ARCT) | 3.1 | $77M | 1.8M | 42.90 | |
| Arena Pharmaceuticals Com New Call Option | 2.7 | $66M | 888k | 74.79 | |
| Royalty Pharma Shs Cl A (RPRX) | 2.5 | $63M | 1.5M | 42.07 | |
| Amgen (AMGN) | 2.4 | $59M | 234k | 254.16 | |
| Teleflex Incorporated (TFX) | 2.3 | $56M | 165k | 340.42 | |
| Charles River Laboratories (CRL) | 2.2 | $55M | 242k | 226.45 | |
| Mednax (MD) | 2.1 | $53M | 3.2M | 16.28 | |
| Danaher Corporation (DHR) | 1.2 | $31M | 145k | 215.33 | |
| Tenet Healthcare Corp Com New (THC) | 1.1 | $27M | 1.1M | 24.51 | |
| Stryker Corporation (SYK) | 1.0 | $25M | 119k | 208.37 | |
| Edwards Lifesciences (EW) | 0.7 | $18M | 224k | 79.82 | |
| Zymeworks | 0.6 | $16M | 346k | 46.58 | |
| Assembly Biosciences | 0.3 | $8.5M | 520k | 16.44 | |
| Bristol Myers Squibb (BMY) | 0.3 | $7.6M | 126k | 60.29 | |
| American Well Corp Cl A | 0.3 | $7.4M | 250k | 29.64 | |
| Align Technology (ALGN) | 0.2 | $4.8M | 15k | 327.38 | |
| Athira Pharma (ATHA) | 0.2 | $4.0M | 218k | 18.46 | |
| Dyne Therapeutics (DYN) | 0.1 | $2.4M | 120k | 20.19 | |
| Incyte Corporation (INCY) | 0.1 | $2.0M | 23k | 89.73 | |
| Outset Med (OM) | 0.1 | $1.8M | 35k | 50.00 | |
| BioMarin Pharmaceutical (BMRN) | 0.0 | $1.1M | 15k | 76.10 | |
| Syndax Pharmaceuticals (SNDX) | 0.0 | $475k | 32k | 14.75 |
